Caris Life Sciences, Inc. (CAI) vs Oscar Health, Inc. (OSCR)
A side-by-side comparison of Caris Life Sciences, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAI
Caris Life Sciences, Inc.
$27.93HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
OSCR
Oscar Health, Inc.
$32.28HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — CAI vs OSCR
growth of $100 · dividends reinvested · last 1yCAI +8.5% (+8.5%/yr)OSCR +101.2% (+101.2%/yr)OSCR compounded faster over this window
CAI OSCR
CAI vs OSCR: by the numbers
- •OSCR is the larger company ($8.37B vs $7.90B market cap).
- •OSCR trades at the lower trailing earnings multiple (23.06 vs 78.04 P/E), one valuation lens rather than an overall verdict.
- •CAI converts more revenue to profit (10.62% vs 3.60% net margin).
- •OSCR grew revenue faster over the past five years (64.83% vs 26.15% CAGR).
Metrics side by side
Valuation
| Metric | CAI | OSCR |
|---|---|---|
| P/E ratio | 78.04 | 23.06 |
| Forward P/E | 240.71 | 16.91 |
| P/S ratio | 7.98 | 0.55 |
| P/B ratio | 13.34 | 4.08 |
| EV / EBITDA | 44.00 | 7.24 |
| FCF yield | 1.86% | 51.80% |
Profitability
| Metric | CAI | OSCR |
|---|---|---|
| Gross margin | 69.66% | 14.38% |
| Operating margin | 5.56% | 4.07% |
| Net margin | 10.62% | 3.60% |
| ROE | 17.77% | 26.84% |
| ROIC | 14.76% | 22.98% |
Growth (annualized)
| Metric | CAI | OSCR |
|---|---|---|
| Revenue CAGR (5Y) | 26.15% | 64.83% |
| FCF CAGR (5Y) | N/A | 80.81% |
| Total return CAGR (5Y) | N/A | 14.97% |
Frequently asked
- Which has the lower trailing P/E, CAI or OSCR?
- OSCR has the lower trailing P/E: CAI trades at 78.04 and OSCR at 23.06. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, CAI or OSCR?
- Over the past five years, OSCR grew revenue faster — CAI at a 26.15% CAGR versus OSCR at 64.83%.
- Is CAI or OSCR more profitable?
- CAI runs the higher net margin — CAI at 10.62% versus OSCR at 3.60%.
Go deeper
Dig into the metrics
Caris Life Sciences P/E ratioOscar Health P/E ratioCaris Life Sciences ROEOscar Health ROECaris Life Sciences operating marginOscar Health operating marginCaris Life Sciences revenue growthOscar Health revenue growthCaris Life Sciences free cash flowOscar Health free cash flow
Caris Life Sciences & Oscar Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.